Cryptococcosis Market By Treatment (Amphotericin B, Flucytosine, Fluconazole) - Growth, Future Prospects And Competitive Analysis 2017 - 2025
Cryptococcosis is a potentially fatal fungal disease occurs due to Cryptococcus. Factors such, increase in prevalence of fatal fungal disease, rising treatment awareness and last-stage HIV patients developing the disease are driving the growth of Cryptococcosis market worldwide.
The report titled “Cryptococcosis Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall Cryptococcosis market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on treatment type (Amphotericin B, Flucytosine, Fluconazole and Others treatment options) and different geographical regions.
In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global Cryptococcosis market, attractive investment proposition and market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:
Geographically, the global Cryptococcosis market is studied for the following regional markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East and Africa
Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global Cryptococcosis market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global Cryptococcosis market. This report concludes with company profiles section that highlights major information about the key players engaged in global Cryptococcosis market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global Cryptococcosis market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Cryptococcosis Market Snapshot
2.2 Global Cryptococcosis Market, by Treatment Type, 2016 (US$ Bn)
2.3 Global Cryptococcosis Market Share, by Geography, 2016 (Value %)
Chapter 3 Cryptococcosis Market Analysis
3.1 Global Cryptococcosis Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Significant Unmet Need
3.2.1.2 High prevalence of Cryptococcosis and other fungal diseases
3.2.2 Challenges
3.2.2.1 Poor Patient Compliance in some countries
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Cryptococcosis Market
Chapter 4 Global Cryptococcosis Market, by Treatment Type
4.1 Overview
4.2 Amphotericin B
4.3 Flucytosine
4.4 Fluconazole
4.5 Other (Voriconazole, surgery treatment, etc.)
Chapter 5 Global Cryptococcosis Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa
Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Alkopharma Inc.
6.3 Astellas Pharma Inc.
6.4 Bristol-Myers Squibb Company
6.5 Glenmark Pharmaceuticals
6.6 Janssen Biotech, Inc. (a Johnson & Johnson)
6.7 Novartis AG
6.8 Pfizer Inc.
6.9 Sigmapharm Laboratories LLC.
6.10 Valeant Pharmaceuticals, Inc.
TABLE 1 Market Positioning of Key Players in Global Cryptococcosis Market
TABLE 2 Global Cryptococcosis Market, by Treatment Type, 2015 – 2025 (US$ Bn)
TABLE 3 Global Cryptococcosis Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 4 North America Cryptococcosis Market, 2015 – 2025 (US$ Bn)
TABLE 5 Europe Cryptococcosis Market, 2015 – 2025 (US$ Bn)
TABLE 6 Asia Pacific Cryptococcosis Market, 2015 – 2025 (US$ Bn)
TABLE 7 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 8 Alkopharma INC.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 9 Astellas Pharma INC.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 10 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 Glenmark Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 Janssen Biotech, Inc. (a Johnson & Johnson): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 Sigmapharm Laboratories LLC.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Valeant Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
FIG. 1 Cryptococcosis Market: Research Methodology
FIG. 2 Global Cryptococcosis Market, by Treatment Type, 2016 (US$ Bn)
FIG. 3 Global Cryptococcosis Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Cryptococcosis Market, by Geography, 2016
FIG. 1 Global Amphotericin B Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 1 Global Flucytosine Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 1 Global Fluconazole Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 1 Global Other (Voriconazole, surgery treatment) Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 2 Latin America Cryptococcosis Market, 2015 – 2025 (US$ Bn)
FIG. 3 Middle East and Africa Cryptococcosis Market, 2015 – 2025 (US$ Bn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)